OBJECTIVE to develope and characterize psoralen loadedPLGAnanoparticlesfortopical formulation, with the final goal of reducing the toxicity and improving the efficacy of PUVA therapy.
Its delivery method is based on a well-characterized, FDA approved biodegradable chemical platform called PLGA. The company's nanoparticles incorporate a high density of attachment sites on their surface, enabling them to carry out multiple functions--like targeting tumors, enhancing diagnostic images, treating diseased tissue or concealing the whole package from the body's natural defenses.